[blockquote align=””]
Sudden and severe onset of obsessive-compulsive disorder (OCD) may present secondary to infectious and/or immune-mediated triggers. We assessed the preliminary efficacy, tolerability, and safety of azithromycin compared with placebo in the treatment of OCD and associated symptoms in children with pediatric acute-onset neuropsychiatric syndrome (PANS).[/blockquote]
[button style=”arrow-right” title=”View the article here” url=”https://www.ncbi.nlm.nih.gov/pubmed/28358599″]
